Health Condition 1: C159- Malignant neoplasm of esophagus, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
Yanpothung Yanthan
Eligibility
Inclusion criteria
Inclusion criteria: 1. Histologically confirmed esophageal cancer (adenocarcinoma or squamous cell carcinoma). 2. Clinical staging via upper gastrointestinal endoscopy with biopsy and CT-scan of Thorax abdomen & pelvis or FDG PET/CT. 3. Treated with definitive radiotherapy with or without concurrent chemotherapy between January 2021 and June 2023. 4. Documented follow-up data available.
Exclusion criteria
Exclusion criteria: 1. Previous treatment for esophageal cancer. 2. Palliative treatment intent. 3. Incomplete radiotherapy or loss to follow-up immediately after treatment. 4. Incomplete medical records. 5. Concurrent primary malignancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To estimate the 2-year progression free survival (PFS) in patients of esophageal cancer treated with definitive chemoradiotherapy.Timepoint: 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| To estimate the 2-year overall survival (OS) in patients of esophageal cancer treated with definitive chemoradiotherapy.Timepoint: 2 years;To assess the incidence and severity of treatment-related toxicities.Timepoint: 2 years;To analyse the patterns of failure.Timepoint: 2 years | — |
Countries
India
Contacts
Public ContactYanpothung Yanthan
Dr. B. Borooah Cancer Institute
Outcome results
None listed